| 摘要 |
The present invention relates to a pharmaceutical composition or a functional health food comprising a gypenoside extract of gynostemma pentaphyllum, as an active ingredient, which contains at least one dammarane-based triterpenoid saponin compounds selected from the group consisting of gypenoside UL1, gypenoside UL2, gypenoside UL3, gypenoside UL4, gypenoside UL5, gypenoside UL6, gypenoside Ul7, and gypenoside XLVIII for treating or preventing obesity, type II diabetes, or hyperlipidemia. |
